<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="lose">
            <roleset id="lose.01" name="" wordnet="1, 8">
                <roles>
                    <role n="0" descr="entity losing something&#x0A;" />
                    <role n="1" descr="thing lost&#x0A;" />
                    <role n="2" descr="situation inducing thing lost&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>A Sph I cleavage site within exon 3 is able to be lost in a new transthyretin variant that has been characterized.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">A Sph I cleavage site within exon 3</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>A Sph I cleavage site within exon 3 is observed to be lost in a new transthyretin variant that has been characterized.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">A Sph I cleavage site within exon 3</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>It was reported that GPI anchoring ability has been lost when the microsomal membranes of Trypanosoma brucei were washed at high pH (Sharma et al., 2000), whereas similar treatment of the mammalian microsomal membranes had no effect (Vidugiriene and Menon, 1995)</text>
                    <arg n="1">GPI anchoring ability</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at high pH</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>No known plastid has the ability to completely lose its prokaryote-type organelle genome, but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">No known plastid</arg>
                    <arg n="1">its prokaryote-type organelle genome</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>No known plastid is able to completely lose its prokaryote-type organelle genome, but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">No known plastid</arg>
                    <arg n="1">its prokaryote-type organelle genome</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>No known plastid is completely losing its prokaryote-type organelle genome, but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">No known plastid</arg>
                    <arg n="1">its prokaryote-type organelle genome</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>No severe complications have been reported, and after the BIB removal, subjects are maintaining the obtained results but some of them can probably lose weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic cleavage, leading to truncated species that may probably lose the first 20 70 residues but that retain enzymatic activity and dimeric structure.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>Stat3 is activated in v-Src or v-abl-transformed cells and, along other Stats, in acute T-cell leukemia cells that may probably lose IL-2 dependency (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T-cell leukemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>Stat3 is activated in v-Src or v-abl-transformed cells and, along other Stats, in acute T-cell leukemia cells that will lose IL-2 dependency (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T-cell leukemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>The C-terminal-deletion mutant of hnRNP A1 lost the ability to interact with the X protein and to bring it into the initiation complex, resulting in an inhibition of MHV RNA transcription and replication.</text>
                    <arg n="0">The C-terminal-deletion mutant of hnRNP A1</arg>
                    <arg n="1">the ability to interact with the X protein and to bring it into the initiation complex</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>These interactions have a high probability of being lost with a separation of DNA-binding sites of }3 bp, as can occur for natural SRE sequences, while a smaller spacing inhibited the simultaneous binding of both proteins.</text>
                    <arg n="1">These interactions</arg>
                    <arg n="2">with a separation of DNA-binding sites of }3 bp</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>These interactions may be lost with a separation of DNA-binding sites of }3 bp, as can occur for natural SRE sequences, while a smaller spacing inhibited the simultaneous binding of both proteins.</text>
                    <arg n="1">These interactions</arg>
                    <arg n="2">with a separation of DNA-binding sites of }3 bp</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>This study investigated whether informing obese individuals that they lost only modest amounts of weight would lead them to adopt more realistic weight loss expectations.</text>
                    <arg n="0">they</arg>
                    <arg n="1">modest amounts of weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>This study investigated whether informing obese individuals that they will lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations.</text>
                    <arg n="0">they</arg>
                    <arg n="1">modest amounts of weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>To this end, we made aggregation chimeras between Lc/+ mice, which have a high probability of losing all Purkinje cells postnatally, and +/+ control mice.</text>
                    <arg n="0">aggregation chimeras between Lc/+ mice</arg>
                    <arg n="1">Purkinje cells</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>To this end, we made aggregation chimeras between Lc/+ mice, which have the ability to lose all Purkinje cells postnatally, and +/+ control mice.</text>
                    <arg n="0">aggregation chimeras between Lc/+ mice</arg>
                    <arg n="1">Purkinje cells</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>To this end, we made aggregation chimeras between Lc/+ mice, which would probably lose all Purkinje cells postnatally, and +/+ control mice.</text>
                    <arg n="0">aggregation chimeras between Lc/+ mice</arg>
                    <arg n="1">Purkinje cells</arg>
                </example>
                <example src="MEDLINE" no="1">
                    <text>The mice did not lose weight during the treatment.</text>
                    <arg n="0">The mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during the treatment</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>Purkinje cells will be lost in aggregation chimeras between Lc/+ mice that has been characterized.</text>
                    <arg n="0">aggregation chimeras between Lc/+ mice</arg>
                    <arg n="1">Purkinje cells</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>Stat3 is activated in v-Src or v-abl-transformed cells and, along other Stats, in A new transthyretin variant that can lose a Sph I cleavage site within exon 3 (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">A new transthyretin variant</arg>
                    <arg n="1">a Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>Stat3 is activated in v-Src or v-abl-transformed cells and, along other Stats, in A new transthyretin variant that have lost a Sph I cleavage site within exon 3 (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">A new transthyretin variant</arg>
                    <arg n="1">a Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>Stat3 is activated in v-Src or v-abl-transformed cells and, along other Stats, in A new transthyretin variant that lost a Sph I cleavage site within exon 3 (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">A new transthyretin variant</arg>
                    <arg n="1">a Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>Stat3 is activated in v-Src or v-abl-transformed cells and, along other Stats, in A new transthyretin variant that will lose a Sph I cleavage site within exon 3 (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">A new transthyretin variant</arg>
                    <arg n="1">a Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>Stat3 is activated in v-Src or v-abl-transformed cells and, along other Stats, in No known plastid that are observed to lose its prokaryote-type organelle genome (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">No known plastid</arg>
                    <arg n="1">its prokaryote-type organelle genome</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>Stat3 is activated in v-Src or v-abl-transformed cells and, along other Stats, in a new transthyretin variant losing A Sph I cleavage site within exon 3 (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">A Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>Stat3 is activated in v-Src or v-abl-transformed cells and, along other Stats, in aggregation chimeras between Lc/+ mice that can probably lose Purkinje cells (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">aggregation chimeras between Lc/+ mice</arg>
                    <arg n="1">Purkinje cells</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>Stat3 is activated in v-Src or v-abl-transformed cells and, along other Stats, in aggregation chimeras between Lc/+ mice that may probably lose Purkinje cells (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">aggregation chimeras between Lc/+ mice</arg>
                    <arg n="1">Purkinje cells</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>To this end, we made A new transthyretin variant, which can lose all a Sph I cleavage site within exon 3 postnatally, and +/+ control mice.</text>
                    <arg n="0">A new transthyretin variant</arg>
                    <arg n="1">a Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>To this end, we made A new transthyretin variant, which have a high probability of losing all a Sph I cleavage site within exon 3 postnatally, and +/+ control mice.</text>
                    <arg n="0">A new transthyretin variant</arg>
                    <arg n="1">a Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>To this end, we made A new transthyretin variant, which lost all a Sph I cleavage site within exon 3 postnatally, and +/+ control mice.</text>
                    <arg n="0">A new transthyretin variant</arg>
                    <arg n="1">a Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>To this end, we made A new transthyretin variant, which might lose all a Sph I cleavage site within exon 3 postnatally, and +/+ control mice.</text>
                    <arg n="0">A new transthyretin variant</arg>
                    <arg n="1">a Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>To this end, we made No known plastid, which has lost all its prokaryote-type organelle genome postnatally, and +/+ control mice.</text>
                    <arg n="0">No known plastid</arg>
                    <arg n="1">its prokaryote-type organelle genome</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>To this end, we made No known plastid, which have a high probability of losing all its prokaryote-type organelle genome postnatally, and +/+ control mice.</text>
                    <arg n="0">No known plastid</arg>
                    <arg n="1">its prokaryote-type organelle genome</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>To this end, we made a new transthyretin variant, which can lose all A Sph I cleavage site within exon 3 postnatally, and +/+ control mice.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">A Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>To this end, we made acute T-cell leukemia cells, which are able to lose all IL-2 dependency postnatally, and +/+ control mice.</text>
                    <arg n="0">acute T-cell leukemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>To this end, we made acute T-cell leukemia cells, which are observed to lose all IL-2 dependency postnatally, and +/+ control mice.</text>
                    <arg n="0">acute T-cell leukemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>To this end, we made acute T-cell leukemia cells, which could lose all IL-2 dependency postnatally, and +/+ control mice.</text>
                    <arg n="0">acute T-cell leukemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>To this end, we made acute T-cell leukemia cells, which could lose all IL-2 dependency postnatally, and +/+ control mice.</text>
                    <arg n="0">acute T-cell leukemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>To this end, we made acute T-cell leukemia cells, which may lose all IL-2 dependency postnatally, and +/+ control mice.</text>
                    <arg n="0">acute T-cell leukemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>To this end, we made acute T-cell leukemia cells, which might lose all IL-2 dependency postnatally, and +/+ control mice.</text>
                    <arg n="0">acute T-cell leukemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>a Sph I cleavage site within exon 3 can be lost in A new transthyretin variant that has been characterized.</text>
                    <arg n="0">A new transthyretin variant</arg>
                    <arg n="1">a Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>a Sph I cleavage site within exon 3 was lost in A new transthyretin variant that has been characterized.</text>
                    <arg n="0">A new transthyretin variant</arg>
                    <arg n="1">a Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>a new transthyretin variant being able to lose A Sph I cleavage site within exon 3 has been characterized.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">A Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>a new transthyretin variant which lost A Sph I cleavage site within exon 3 has been characterized.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">A Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>a new transthyretin variant will completely lose A Sph I cleavage site within exon 3, but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">A Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>acute T-cell leukemia cells is able to completely lose IL-2 dependency, but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">acute T-cell leukemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>acute T-cell leukemia cells observed to lose IL-2 dependency has been characterized.</text>
                    <arg n="0">acute T-cell leukemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>aggregation chimeras between Lc/+ mice can completely lost Purkinje cells, but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">aggregation chimeras between Lc/+ mice</arg>
                    <arg n="1">Purkinje cells</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>aggregation chimeras between Lc/+ mice has completely lost Purkinje cells, but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">aggregation chimeras between Lc/+ mice</arg>
                    <arg n="1">Purkinje cells</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>all A Sph I cleavage site within exon 3 are observed to be postnatally lost by a new transthyretin variant.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">A Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>all A Sph I cleavage site within exon 3 can probably be postnatally lost by a new transthyretin variant.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">A Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>all A Sph I cleavage site within exon 3 might probably be postnatally lost by a new transthyretin variant.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">A Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>all IL-2 dependency are postnatally lost by acute T-cell leukemia cells.</text>
                    <arg n="0">acute T-cell leukemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>all a Sph I cleavage site within exon 3 are observed to be postnatally lost by A new transthyretin variant.</text>
                    <arg n="0">A new transthyretin variant</arg>
                    <arg n="1">a Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>all a Sph I cleavage site within exon 3 would probably be postnatally lost by A new transthyretin variant.</text>
                    <arg n="0">A new transthyretin variant</arg>
                    <arg n="1">a Sph I cleavage site within exon 3</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>all its prokaryote-type organelle genome may be postnatally lost by No known plastid.</text>
                    <arg n="0">No known plastid</arg>
                    <arg n="1">its prokaryote-type organelle genome</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>Stat3 is activated in v-Src or v-abl-transformed cells and, along other Stats, in they that lost modest amounts of weight (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">they</arg>
                    <arg n="1">modest amounts of weight</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>Stat3 is activated in v-Src or v-abl-transformed cells and, along other Stats, in they that lost modest amounts of weight (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">they</arg>
                    <arg n="1">modest amounts of weight</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>The C-terminal-deletion mutant of hnRNP A1 which has lost the ability to interact with the X protein and to bring it into the initiation complex has been characterized.</text>
                    <arg n="0">The C-terminal-deletion mutant of hnRNP A1</arg>
                    <arg n="1">the ability to interact with the X protein and to bring it into the initiation complex</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>To this end, we made some of them, which can lose all weight postnatally, and +/+ control mice.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>To this end, we made some of them, which have the ability to lose all weight postnatally, and +/+ control mice.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>To this end, we made some of them, which have the ability to lose all weight postnatally, and +/+ control mice.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>To this end, we made they, which are observed to lose all modest amounts of weight postnatally, and +/+ control mice.</text>
                    <arg n="0">they</arg>
                    <arg n="1">modest amounts of weight</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>To this end, we made truncated species, which are able to lose all the first 20 70 residues postnatally, and +/+ control mice.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>To this end, we made truncated species, which may lose all the first 20 70 residues postnatally, and +/+ control mice.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>To this end, we made truncated species, which may probably lose all the first 20 70 residues postnatally, and +/+ control mice.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>To this end, we made truncated species, which may probably lose all the first 20 70 residues postnatally, and +/+ control mice.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>all modest amounts of weight could probably be postnatally lost by they.</text>
                    <arg n="0">they</arg>
                    <arg n="1">modest amounts of weight</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>all the ability to interact with the X protein and to bring it into the initiation complex will probably be postnatally lost by The C-terminal-deletion mutant of hnRNP A1.</text>
                    <arg n="0">The C-terminal-deletion mutant of hnRNP A1</arg>
                    <arg n="1">the ability to interact with the X protein and to bring it into the initiation complex</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>all the first 20 70 residues could be postnatally lost by truncated species.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>all weight might be postnatally lost by some of them.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>modest amounts of weight has been lost in they that has been characterized.</text>
                    <arg n="0">they</arg>
                    <arg n="1">modest amounts of weight</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>some of them can completely lost weight, but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>some of them completely loses weight, but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>some of them which can lose weight has been characterized.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>some of them will completely lose weight, but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>they is observed to completely lose modest amounts of weight, but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">they</arg>
                    <arg n="1">modest amounts of weight</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>truncated species losing the first 20 70 residues has been characterized.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>weight is lost in some of them that has been characterized.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
